CAMP signalling in the vasculature: The role of Epac (exchange protein directly activated by cAMP)

Biochemical Society Transactions

Volumn 42, Issue 1, 2014, Pages 89-97

  Roberts, Owain Llŷr ^a   Dart, Caroline ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

CAMP; Endothelial barrier function; Exchange protein directly activated by cAMP (Epac); Guanine nucleotide exchange factor (GEF); Protein kinase A (PKA); Vascular smooth muscle; Vasculature; Vasodilatation

Indexed keywords

ACTIN; ANTIPORTER; CADHERIN; CALCITONIN GENE RELATED PEPTIDE; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CAMP; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MESSENGER RNA; PROSTACYCLIN; PROSTAGLANDIN E2; RAP1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL; BLOOD VESSEL TONE; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; HUMAN; INFLAMMATION; NONHUMAN; PERMEABILITY BARRIER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SMOOTH MUSCLE CONTRACTILITY; SMOOTH MUSCLE FIBER; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASCULARIZATION;

ANIMALS; BLOOD VESSELS; CAPILLARY PERMEABILITY; CELL ADHESION; CELL MOVEMENT; CYCLIC AMP; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEMODYNAMICS; HUMANS; SECOND MESSENGER SYSTEMS;

EID: 84893221279     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20130253     Document Type: Article

References (93)

1. Patterson, C.E., Lum, H., Schaphorst, K.L., Verin, A.D. and Garcia, J.G. (2000) Regulation of endothelial barrier function by the cAMP-dependent protein kinase. Endothelium 7, 287-308
2. Indolfi, C., Avvedimento, E.V., Di Lorenzo, E., Esposito, G., Rapacciuolo, A., Giuliano, P., Grieco, D., Cavuto, L., Stingone, A.M., Ciullo, I. et al. (1997) Activation of cAMP-PKA signaling in vivo inhibits smooth muscle cell proliferation induced by vascular injury. Nat. Med. 3, 775-779
3. Morgado, M., Cairrao, E., Santos-Silva, A.J. and Verde, I. (2012) Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle. Cell. Mol. Life Sci. 69, 247-266
4. Haynes, Jr, J., Robinson, J., Saunders, L., Taylor, A.E. and Strada, S.J. (1992) Role of cAMP-dependent protein kinase in cAMP-mediated vasodilation. Am. J. Physiol. 262, H511-H516
5. Eckly-Michel, A., Martin, V. and Lugnier, C. (1997) Involvement of cyclic nucleotide-dependent protein kinases in cyclic AMP-mediated vasorelaxation. Br. J. Pharmacol. 122, 158-164
6. Yao, X., Leung, P.S., Kwan, H.Y., Wong, T.P. and Fong, M.W. (1999) Rod-type cyclic nucleotide-gated cation channel is expressed in vascular endothelium and vascular smooth muscle cells. Cardiovasc. Res. 41, 282-290
7. Shen, B., Cheng, K.T., Leung, Y.K., Kwok, Y.C., Kwan, H.Y., Wong, C.O., Chen, Z.Y., Huang, Y. and Yao, X. (2008) Epinephrine-induced Ca2+ influx in vascular endothelial cells is mediated by CNGA2 channels. J. Mol. Cell. Cardiol. 45, 437-445
8. Leung, Y.K., Du, J., Huang, Y. and Yao, X. (2010) Cyclic nucleotide-gated channels contribute to thromboxane A2-induced contraction of rat small mesenteric arteries. PLoS ONE 5, e11098
9. Gloerich, M. and Bos, J.L. (2010) Epac: defining a new mechanism for cAMP action. Annu. Rev. Pharmacol. Toxicol. 50, 355-375
10. Schmidt, M., Dekker, F.J. and Maarsingh, H. (2013) Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol. Rev. 65, 670-709
11. Yang, S.K., Xiao, L., Li, J., Liu, F., Sun, L. and Kanwar, Y.S. (2013) Role of guanine-nucleotide exchange factor Epac in renal physiology and pathophysiology. Am. J. Physiol. Renal Physiol. 304, F831-F839
12. Grandoch, M., Roscioni, S.S. and Schmidt, M. (2010) The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. Br. J. Pharmacol. 159, 265-284
13. Laurent, A.C., Breckler, M., Berthouze, M. and Lezoualc'h, F. (2012) Role of Epac in brain and heart. Biochem. Soc. Trans. 40, 51-57
14. Kawasaki, H., Springett, G.M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D.E. and Graybiel, A.M. (1998) A family of cAMP-binding proteins that directly activate Rap1. Science 282, 2275-2279
15. de Rooij, J., Zwartkruis, F.J., Verheijen, M.H., Cool, R.H., Nijman, S.M., Wittinghofer, A. and Bos, J.L. (1998) Epac is a Rap1 guanine-nucleotide- exchange factor directly activated by cyclic AMP. Nature 396, 474-477
16. de Rooij, J., Rehmann, H., van Triest, M., Cool, R.H., Wittinghofer, A. and Bos, J.L. (2000) Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J. Biol. Chem. 275, 20829-20836
17. Niimura, M., Miki, T., Shibasaki, T., Fujimoto, W., Iwanaga, T. and Seino, S. (2009) Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J. Cell. Physiol. 219, 652-658
18. Ueno, H., Shibasaki, T., Iwanaga, T., Takahashi, K., Yokoyama, Y., Liu, L.M., Yokoi, N., Ozaki, N., Matsukura, S., Yano, H. and Seino, S. (2001) Characterization of the gene EPAC2: structure, chromosomal localization, tissue expression, and identification of the liver-specific isoform. Genomics 78, 91-98
19. Purves, G.I., Kamishima, T., Davies, L.M., Quayle, J.M. and Dart, C. (2009) Exchange protein activated by cAMP (Epac) mediates cAMP-dependent but protein kinase A-insensitive modulation of vascular ATP-sensitive potassium channels. J. Physiol. 587, 3639-3650
20. Zieba, B.J., Artamonov, M.V., Jin, L., Momotani, K., Ho, R., Franke, A.S., Neppl, R.L., Stevenson, A.S., Khromov, A.S., Chrzanowska-Wodnicka, M. and Somlyo, A.V. (2011) The cAMP-responsive Rap1 guanine nucleotide exchange factor, Epac, induces smooth muscle relaxation by down-regulation of RhoA activity. J. Biol. Chem. 286, 16681-16692
21. Roberts, O.L., Kamishima, T., Barrett-Jolley, R., Quayle, J.M. and Dart, C. (2013) Exchange protein activated by cAMP (Epac) induces vascular relaxation by activating Ca2+ -sensitive K+ channels in rat mesenteric artery. J. Physiol. 591, 5107-5123
22. Roscioni, S.S., Maarsingh, H., Elzinga, C.R., Schuur, J., Menzen, M., Halayko, A.J., Meurs, H. and Schmidt, M. (2011) Epac as a novel effector of airway smooth muscle relaxation. J. Cell. Mol. Med. 15, 1551-1563
23. Hewer, R.C., Sala-Newby, G.B., Wu, Y.J., Newby, A.C. and Bond, M. (2011) PKA and Epac synergistically inhibit smooth muscle cell proliferation. J. Mol. Cell. Cardiol. 50, 87-98
24. Kooistra, M.R., Corada, M., Dejana, E. and Bos, J.L. (2005) Epac1 regulates integrity of endothelial cell junctions through VE-cadherin. FEBS Lett. 579, 4966-4972
25. Fang, Y. and Olah, M.E. (2007) Cyclic AMP-dependent, protein kinase A-independent activation of extracellular signal-regulated kinase 1/2 following adenosine receptor stimulation in human umbilical vein endothelial cells: role of exchange protein activated by cAMP 1 (Epac1). J. Pharmacol. Exp. Ther. 322, 1189-1200
26. Sehrawat, S., Cullere, X., Patel, S., Italiano, Jr, J. and Mayadas, T.N. (2008) Role of Epac1, an exchange factor for Rap GTPases, in endothelial microtubule dynamics and barrier function. Mol. Biol. Cell 19, 1261-1270
27. Woolson, H.D., Thomson, V.S., Rutherford, C., Yarwood, S.J. and Palmer, T.M. (2009) Selective inhibition of cytokine-activated extracellular signal-regulated kinase by cyclic AMP via Epac1-dependent induction of suppressor of cytokine signalling-3. Cell. Signalling 21, 1706-1715
28. Fukuhara, S., Sakurai, A., Sano, H., Yamagishi, A., Somekawa, S., Takakura, N., Saito, Y., Kangawa, K. and Mochizuki, N. (2005) Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 25, 136-146
29. Tiwari, S., Felekkis, K., Moon, E.Y., Flies, A., Sherr, D.H. and Lerner, A. (2004) Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis. Blood 103, 2661-2667
30. Cullere, X., Shaw, S.K., Andersson, L., Hirahashi, J., Luscinskas, F.W. and Mayadas, T.N. (2005) Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105, 1950-1955
31. Hong, J., Doebele, R.C., Lingen, M.W., Quilliam, L.A., Tang, W.J. and Rosner, M.R. (2007) Anthrax edema toxin inhibits endothelial cell chemotaxis via Epac and Rap1. J. Biol. Chem. 282, 19781-19787
32. Ponsioen, B., Gloerich, M., Ritsma, L., Rehmann, H., Bos, J.L. and Jalink, K. (2009) Direct spatial control of Epac1 by cyclic AMP. Mol. Cell. Biol. 29, 2521-2531
33. Dao, K.K., Teigen, K., Kopperud, R., Hodneland, E., Schwede, F., Christensen, A.E., Martinez, A. and Doskeland, S.O. (2006) Epac1 and cAMP-dependent protein kinase holoenzyme have similar cAMP affinity, but their cAMP domains have distinct structural features and cyclic nucleotide recognition. J. Biol. Chem. 281, 21500-21511
34. Rehmann, H., Das, J., Knipscheer, P., Wittinghofer, A. and Bos, J.L. (2006) Structure of the cyclic-AMP-responsive exchange factor Epac2 in its auto-inhibited state. Nature 439, 625-628
35. Rehmann, H., Arias-Palomo, E., Hadders, M.A., Schwede, F., Llorca, O. and Bos, J.L. (2008) Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 455, 124-127
36. Rehmann, H., Schwede, F., Doskeland, S.O., Wittinghofer, A. and Bos, J.L. (2003) Ligand-mediated activation of the cAMP-responsive guanine nucleotide exchange factor Epac. J. Biol. Chem. 278, 38548-38556
37. Gittenberger-de Groot, A.C., DeRuiter, M.C., Bergwerff, M. and Poelmann, R.E. (1999) Smooth muscle cell origin and its relation to heterogeneity in development and disease. Arterioscler., Thromb., Vasc. Biol. 19, 1589-1594
38. Dzau, V.J., Braun-Dullaeus, R.C. and Sedding, D.G. (2002) Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat. Med. 8, 1249-1256
39. Lacolley, P., Regnault, V., Nicoletti, A., Li, Z. and Michel, J.B. (2012) The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc. Res. 95, 194-204
40. Marx, S.O., Totary-Jain, H. and Marks, A.R. (2011) Vascular smooth muscle cell proliferation in restenosis. Circ.: Cardiovasc. Interventions 4, 104-111
41. Mayer, P., Hinze, A.V., Harst, A. and von Kugelgen, I. (2011) A2B receptors mediate the induction of early genes and inhibition of arterial smooth muscle cell proliferation via Epac. Cardiovasc. Res. 90, 148-156
42. Gerthoffer, W.T. (2007) Mechanisms of vascular smooth muscle cell migration. Circ. Res. 100, 607-621
43. Yokoyama, U., Minamisawa, S., Quan, H., Akaike, T., Jin, M., Otsu, K., Ulucan, C., Wang, X., Baljinnyam, E., Takaoka, M. et al. (2008) Epac1 is upregulated during neointima formation and promotes vascular smooth muscle cell migration. Am. J. Physiol. Heart Circ. Physiol. 295, H1547-H1555
44. Eid, A.H. (2012) cAMP induces adhesion of microvascular smooth muscle cells to fibronectin via an Epac-mediated but PKA-independent mechanism. Cell. Physiol. Biochem. 30, 247-258
45. Grandoch, M., Hoffmann, J., Rock, K., Wenzel, F., Oberhuber, A., Schelzig, H. and Fischer, J.W. (2013) Novel effects of adenosine receptors on pericellular hyaluronan matrix: implications for human smooth muscle cell phenotype and interactions with monocytes during atherosclerosis. Basic Res. Cardiol. 108, 340
46. Enserink, J.M., Christensen, A.E., de Rooij, J., van Triest, M., Schwede, F., Genieser, H.G., Doskeland, S.O., Blank, J.L. and Bos, J.L. (2002) A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 4, 901-906
47. Sukhanova, I.F., Kozhevnikova, L.M., Popov, E.G., Podmareva, O.N. and Avdonin, P.V. (2006) Activators of Epac proteins induce relaxation of isolated rat aorta. Dokl. Biol. Sci. 411, 441-444
48. Jeyaraj, S.C., Unger, N.T., Eid, A.H., Mitra, S., Paul El-Dahdah, N., Quilliam, L.A., Flavahan, N.A. and Chotani, M.A. (2012) Cyclic AMP-Rap1A signaling activates RhoA to induce α2c-adrenoceptor translocation to the cell surface of microvascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 303, C499-C511
49. Wier, W.G. and Morgan, K.G. (2003) α1-Adrenergic signaling mechanisms in contraction of resistance arteries. Rev. Physiol., Biochem. Pharmacol. 150, 91-139
50. Dejana, E. (2004) Endothelial cell-cell junctions: happy together. Nat. Rev. Mol. Cell Biol. 5, 261-270
51. Dejana, E., Tournier-Lasserve, E. and Weinstein, B.M. (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev. Cell 16, 209-221
52. Bogatcheva, N.V. and Verin, A.D. (2008) The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc. Res. 76, 202-207
53. Prasain, N. and Stevens, T. (2009) The actin cytoskeleton in endothelial cell phenotypes. Microvasc. Res. 77, 53-63
54. Spindler, V., Peter, D., Harms, G.S., Asan, E. and Waschke, J. (2011) Ultrastructural analysis reveals cAMP-dependent enhancement of microvascular endothelial barrier functions via Rac1-mediated reorganization of intercellular junctions. Am. J. Pathol. 178, 2424-2436
55. Sehrawat, S., Ernandez, T., Cullere, X., Takahashi, M., Ono, Y., Komarova, Y. and Mayadas, T.N. (2011) AKAP9 regulation of microtubule dynamics promotes Epac1-induced endothelial barrier properties. Blood 117, 708-718
56. Aslam, M., Schluter, K.D., Rohrbach, S., Rafiq, A., Nazli, S., Piper, H.M., Noll, T., Schulz, R. and Gunduz, D. (2013) Hypoxia-reoxygenationinduced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase. J. Physiol. 591, 461-473
57. Adamson, R.H., Ly, J.C., Sarai, R.K., Lenz, J.F., Altangerel, A., Drenckhahn, D. and Curry, F.E. (2008) Epac/Rap1 pathway regulates microvascular hyperpermeability induced by PAF in rat mesentery. Am. J. Physiol. Heart Circ. Physiol. 294, H1188-H1196
58. Rampersad, S.N., Ovens, J.D., Huston, E., Umana, M.B., Wilson, L.S., Netherton, S.J., Lynch, M.J., Baillie, G.S., Houslay, M.D. and Maurice, D.H. (2010) Cyclic AMP phosphodiesterase 4D (PDE4D) tethers EPAC1 in a vascular endothelial cadherin (VE-Cad)-based signaling complex and controls cAMP-mediated vascular permeability. J. Biol. Chem. 285, 33614-33622
59. Shen, Q., Rigor, R.R., Pivetti, C.D., Wu, M.H. and Yuan, S.Y. (2010) Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc. Res. 87, 272-280
60. Birukova, A.A., Burdette, D., Moldobaeva, N., Xing, J., Fu, P. and Birukov, K.G. (2010) Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMP. Microvasc. Res. 79, 128-138
61. van Nieuw Amerongen, G.P. and van Hinsbergh, V.W. (2001) Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler., Thromb., Vasc. Biol. 21, 300-311
62. Amano, M., Ito, M., Kimura, K., Fukata, Y., Chihara, K., Nakano, T., Matsuura, Y. and Kaibuchi, K. (1996) Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J. Biol. Chem. 271, 20246-20249
63. Beckers, C.M., van Hinsbergh, V.W. and van Nieuw Amerongen, G.P. (2010) Driving Rho GTPase activity in endothelial cells regulates barrier integrity. Thromb. Haemostasis 103, 40-55
64. Baumer, Y., Spindler, V., Werthmann, R.C., Bunemann, M. and Waschke, J. (2009) Role of Rac 1 and cAMP in endothelial barrier stabilization and thrombin-induced barrier breakdown. J. Cell. Physiol. 220, 716-726
65. Birukova, A.A., Zagranichnaya, T., Fu, P., Alekseeva, E., Chen, W., Jacobson, J.R. and Birukov, K.G. (2007) Prostaglandins PGE2 and PGI2 promote endothelial barrier enhancement via PKA- and Epac1/Rap1-dependent Rac activation. Exp. Cell Res. 313, 2504-2520
66. Pannekoek, W.J., van Dijk, J.J., Chan, O.Y., Huveneers, S., Linnemann, J.R., Spanjaard, E., Brouwer, P.M., van der Meer, A.J., Zwartkruis, F.J., Rehmann, H. et al. (2011) Epac1 and PDZ-GEF cooperate in Rap1 mediated endothelial junction control. Cell. Signalling 23, 2056-2064
67. Pannekoek, W.J., Kooistra, M.R., Zwartkruis, F.J. and Bos, J.L. (2009) Cell-cell junction formation: the role of Rap1 and Rap1 guanine nucleotide exchange factors. Biochim. Biophys. Acta 1788, 790-796
68. Meijer, L.A., Zhou, H., Chan, O.Y., Altelaar, A.F., Hennrich, M.L., Mohammed, S., Bos, J.L. and Heck, A.J. (2013) Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Mol. BioSyst. 9, 732-749
69. Sands, W.A., Woolson, H.D., Milne, G.R., Rutherford, C. and Palmer, T.M. (2006) Exchange protein activated by cyclic AMP (Epac)-mediated induction of suppressor of cytokine signaling 3 (SOCS-3) in vascular endothelial cells. Mol. Cell. Biol. 26, 6333-6346
70. Yarwood, S.J., Borland, G., Sands, W.A. and Palmer, T.M. (2008) Identification of CCAAT/enhancer-binding proteins as exchange protein activated by cAMP-activated transcription factors that mediate the induction of the SOCS-3 gene. J. Biol. Chem. 283, 6843-6853
71. Ley, K., Laudanna, C., Cybulsky, M.I. and Nourshargh, S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7, 678-689
72. Park, T.Y., Baik, E.J. and Lee, S.H. (2013) Prostaglandin E2-induced intercellular adhesion molecule-1 expression is mediated by cAMP/Epac signalling modules in bEnd.3 brain endothelial cells. Br. J. Pharmacol. 169, 604-618
73. Lorenowicz, M.J., van Gils, J., de Boer, M., Hordijk, P.L. and Fernandez-Borja, M. (2006) Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis. J. Leukocyte Biol. 80, 1542-1552
74. Lorenowicz, M.J., Fernandez-Borja, M. and Hordijk, P.L. (2007) cAMP signaling in leukocyte transendothelial migration. Arterioscler., Thromb., Vasc. Biol. 27, 1014-1022
75. Carmona, G., Chavakis, E., Koehl, U., Zeiher, A.M. and Dimmeler, S. (2008) Activation of Epac stimulates integrin-dependent homing of progenitor cells. Blood 111, 2640-2646
76. Yang, F., Liu, S., Yu, C., Wang, S.J., Paganini-Hill, A. and Fisher, M.J. (2012) PDE4 regulates tissue plasminogen activator expression of human brain microvascular endothelial cells. Thromb. Res. 129, 750-753
77. Rondaij, M.G., Sellink, E., Gijzen, K.A., ten Klooster, J.P., Hordijk, P.L., van Mourik, J.A. and Voorberg, J. (2004) Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor from endothelial cells. Arterioscler., Thromb., Vasc. Biol. 24, 1315-1320
78. van Hooren, K.W., van Agtmaal, E.L., Fernandez-Borja, M., van Mourik, J.A., Voorberg, J. and Bierings, R. (2012) The Epac-Rap1 signaling pathway controls cAMP-mediated exocytosis of Weibel-Palade bodies in endothelial cells. J. Biol. Chem. 287, 24713-24720
79. Lowenstein, C.J., Morrell, C.N. and Yamakuchi, M. (2005) Regulation of Weibel-Palade body exocytosis. Trends Cardiovasc. Med. 15, 302-308
80. Hillgruber, C., Steingraber, A.K., Poppelmann, B., Denis, C.V., Ware, J., Vestweber, D., Nieswandt, B., Schneider, S.W. and Goerge, T. (2014) Blocking von Willebrand factor for treatment of cutaneous inflammation. J. Invest. Dermatol. 134, 77-86
81. De Meyer, S.F., Stoll, G., Wagner, D.D. and Kleinschnitz, C. (2012) von Willebrand factor: an emerging target in stroke therapy. Stroke 43, 599-606
82. Panes, J., Perry, M. and Granger, D.N. (1999) Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention. Br. J. Pharmacol. 126, 537-550
83. Lamalice, L., Le Boeuf, F. and Huot, J. (2007) Endothelial cell migration during angiogenesis. Circ. Res. 100, 782-794
84. Netherton, S.J., Sutton, J.A., Wilson, L.S., Carter, R.L. and Maurice, D.H. (2007) Both protein kinase A and exchange protein activated by cAMP coordinate adhesion of human vascular endothelial cells. Circ. Res. 101, 768-776
85. Almahariq, M., Tsalkova, T., Mei, F.C., Chen, H., Zhou, J., Sastry, S.K., Schwede, F. and Cheng, X. (2013) A novel EPAC-specific inhibitor suppresses pancreatic cancer cell migration and invasion. Mol. Pharmacol. 83, 122-128
86. Tsalkova, T., Mei, F.C., Li, S., Chepurny, O.G., Leech, C.A., Liu, T., Holz, G.G., Woods, Jr, V.L. and Cheng, X. (2012) Isoform-specific antagonists of exchange proteins directly activated by cAMP. Proc. Natl. Acad. Sci. U.S.A. 109, 18613-18618
87. Chen, H., Tsalkova, T., Mei, F.C., Hu, Y., Cheng, X. and Zhou, J. (2012) 5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP. Bioorg. Med. Chem. Lett. 22, 4038-4043
88. Rehmann, H. (2013) Epac-inhibitors: facts and artefacts. Sci. Rep. 3, 3032
89. Chrzanowska-Wodnicka, M. (2013) Distinct functions for Rap1 signaling in vascular morphogenesis and dysfunction. Exp. Cell Res. 319, 2350-2359
90. Yang, Y., Shu, X., Liu, D., Shang, Y., Wu, Y., Pei, L., Xu, X., Tian, Q., Zhang, J., Qian, K. et al. (2012) EPAC null mutation impairs learning and social interactions via aberrant regulation of miR-124 and Zif268 translation. Neuron 73, 774-788
91. Aslam, M., Hartel, F.V., Arshad, M., Gunduz, D., Abdallah, Y., Sauer, H., Piper, H.M. and Noll, T. (2010) cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17. Cardiovasc. Res. 87, 375-384
92. Aslam, M., Pfeil, U., Gunduz, D., Rafiq, A., Kummer, W., Piper, H.M. and Noll, T. (2012) Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin-induced barrier failure in endothelial cell monolayers. Br. J. Pharmacol. 165, 208-222
93. Baumer, Y., Drenckhahn, D. and Waschke, J. (2008) cAMP induced Rac 1-mediated cytoskeletal reorganization in microvascular endothelium. Histochem. Cell Biol. 129, 765-778